Mechanistic studies suggested that systemically delivered PR1P targeted cardiac tissue within ischemic zones leading to sustained upregulation of endogenous VEGF signaling beyond that which is normally found during natural recovery from MI in rodents. Here, VEGFA is linked to myocardial infarction.